Zoals ik zei in deze thread worden meer en meer dokters bewust over de gevaren van fina.
Finasteride has been added to the 'list of drugs to avoid in 2021' by a French Medical Journal
Translation from the
Journal 'Drugs to be Avoided for Better Care 2021 Report'
'Finasteride 1mg, a 5-alpha-reductase inhibitor, has a very high efficacy in modest androgenic alopecia in men: it increases hair density only slightly on the top of the head (by about 10%), and only for the duration of the treatment. It exposes particular sexual disorders (e.g., sexual dysfunction in erection and ejaculation, decreased libido), depression, suicidal ideation and cancer of the breast. When a drug is the chosen option, local minoxidil used with care is less dangerous.'
(Finasteride is on page 6 of the journal)
The journal is called Prescrire, a medical journal that 'addresses developments in diseases, medications, and in medical techniques and technologies' and 'contains no advertising'.
According to their
website their 'editors are healthcare professionals, specially trained in Prescrire's editorial methods and free from conflicts of interest. Exacting quality control procedures are applied to all editorial content.'
Bij PSSD (post ssri syndroom) heeft het ook geduurd tot 2019 om medisch erkend te worden als een echt probleem. En ssri's zijn al veel langer op de markt dan fina. (
https://www.psychologytoday.com/us/b...ical-condition )